OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span
Muthiah Vaduganathan, Brian Claggett, Stephen P. Juraschek, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 5, pp. 576-576
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Global Burden of Cardiovascular Diseases and Risk
Muthiah Vaduganathan, George A. Mensah, Justine Varieur Turco, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 25, pp. 2361-2371
Open Access | Times Cited: 1135

2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Eric M. Isselbacher, Ourania Preventza, James H. Black, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 24, pp. e223-e393
Open Access | Times Cited: 277

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Deepak L. Bhatt, Muthiah Vaduganathan, David E. Kandzari, et al.
The Lancet (2022) Vol. 400, Iss. 10361, pp. 1405-1416
Closed Access | Times Cited: 124

2022 ACC/AHA guideline for the diagnosis and management of aortic disease
Eric M. Isselbacher, Ourania Preventza, James H. Black, et al.
Journal of Thoracic and Cardiovascular Surgery (2023) Vol. 166, Iss. 5, pp. e182-e331
Open Access | Times Cited: 59

Trends in Cardiometabolic Mortality in the United States, 1999-2017
Nilay S. Shah, Donald M. Lloyd‐Jones, Martín O’Flaherty, et al.
JAMA (2019) Vol. 322, Iss. 8, pp. 780-780
Open Access | Times Cited: 124

Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity
Orna Reges, Hongyan Ning, John T. Wilkins, et al.
Hypertension (2020) Vol. 77, Iss. 2, pp. 347-356
Open Access | Times Cited: 60

Mediating Effect of Self-Efficacy on the Relationship Between Medication Literacy and Medication Adherence Among Patients With Hypertension
Zhiying Shen, Shuangjiao Shi, Siqing Ding, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 57

Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study
Fengdi Zhang, Kelsey B. Bryant, Andrew E. Moran, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 4

Blood Pressure–Elevating and Antihypertensive Medication Prescription Trends
Ashutosh Kumar, Nicole L. Therrien, John I. Ogwuegbu, et al.
Hypertension (2025)
Closed Access

Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013–2018
Donald Hayes, Sandra L. Jackson, Yanfeng Li, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 6, pp. 514-525
Open Access | Times Cited: 15

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial
Muthiah Vaduganathan, Silvio E. Inzucchi, Naveed Sattar, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 12, pp. 2775-2784
Open Access | Times Cited: 20

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction
Kieran F. Docherty, Pardeep S. Jhund, Brian Claggett, et al.
JAMA Cardiology (2021) Vol. 6, Iss. 11, pp. 1298-1298
Open Access | Times Cited: 17

Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure
Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 19, pp. 1775-1784
Open Access | Times Cited: 12

Brazilian Society for Angiology and Vascular Surgery guidelines on abdominal aortic aneurysm
Grace Carvajal Mulatti, Edwaldo Édner Joviliano, Adamastor Humberto Pereira, et al.
Jornal Vascular Brasileiro (2023) Vol. 22
Open Access | Times Cited: 7

Obesity pillars roundtable: Phentermine – Past, present, and future
Harold Bays, Ethan Lazarus, Craig Primack, et al.
Obesity Pillars (2022) Vol. 3, pp. 100024-100024
Open Access | Times Cited: 11

Identification of a novel frameshift mutation in the SCNN1B causing Liddle syndrome
Yi Qu, Yiting Lu, Di Zhang, et al.
Science Bulletin (2023) Vol. 68, Iss. 4, pp. 383-387
Open Access | Times Cited: 5

Blood pressure management and renal protection: Revisiting hypertensive nephropathy
Ting‐Wei Kao, Chin‐Chou Huang
Journal of the Chinese Medical Association (2021) Vol. 84, Iss. 10, pp. 911-916
Open Access | Times Cited: 10

Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults
Tina K. Reddy, Samar A. Nasser, A.V. Pulapaka, et al.
Current Cardiology Reports (2024)
Open Access | Times Cited: 1

Erhöhter Blutdruck und Bluthochdruck
Raphael Schmieder, Heribert Schunkert
Herz (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top